SACCO, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 7.895
EU - Europa 5.075
AS - Asia 4.366
SA - Sud America 590
Continente sconosciuto - Info sul continente non disponibili 336
AF - Africa 105
OC - Oceania 5
Totale 18.372
Nazione #
US - Stati Uniti d'America 7.558
IT - Italia 1.875
VN - Vietnam 1.331
SG - Singapore 1.150
CN - Cina 803
DE - Germania 710
BR - Brasile 447
RU - Federazione Russa 433
HK - Hong Kong 377
SE - Svezia 367
PL - Polonia 323
CA - Canada 275
FR - Francia 249
IE - Irlanda 198
GB - Regno Unito 178
UA - Ucraina 161
IN - India 144
NL - Olanda 135
DK - Danimarca 113
BD - Bangladesh 86
FI - Finlandia 83
ID - Indonesia 74
AT - Austria 71
TR - Turchia 56
KR - Corea 55
JP - Giappone 54
AR - Argentina 52
ES - Italia 44
ZA - Sudafrica 41
IQ - Iraq 39
MX - Messico 29
CO - Colombia 28
RO - Romania 28
BE - Belgio 25
PK - Pakistan 25
PH - Filippine 22
CH - Svizzera 21
VE - Venezuela 18
CZ - Repubblica Ceca 16
SA - Arabia Saudita 16
CL - Cile 15
EC - Ecuador 14
EG - Egitto 14
IR - Iran 14
LT - Lituania 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
NP - Nepal 12
IL - Israele 11
TN - Tunisia 11
MY - Malesia 10
TW - Taiwan 10
DZ - Algeria 9
MA - Marocco 9
JO - Giordania 8
KE - Kenya 7
CR - Costa Rica 6
AU - Australia 5
EU - Europa 5
LB - Libano 5
NI - Nicaragua 5
PE - Perù 5
TH - Thailandia 5
UY - Uruguay 5
AZ - Azerbaigian 4
BO - Bolivia 4
HN - Honduras 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PA - Panama 4
PT - Portogallo 4
SI - Slovenia 4
BG - Bulgaria 3
CY - Cipro 3
GT - Guatemala 3
MU - Mauritius 3
OM - Oman 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
IS - Islanda 2
JM - Giamaica 2
LK - Sri Lanka 2
MD - Moldavia 2
PS - Palestinian Territory 2
PY - Paraguay 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
CI - Costa d'Avorio 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GL - Groenlandia 1
Totale 18.024
Città #
Ann Arbor 1.734
Ashburn 833
Singapore 696
Milan 635
Frankfurt am Main 572
San Jose 432
Ho Chi Minh City 402
Hong Kong 359
Woodbridge 349
Wilmington 348
Hanoi 300
Kraków 296
Chandler 288
Fairfield 245
Dublin 193
Houston 189
Council Bluffs 168
New York 163
Los Angeles 149
Toronto 146
Jacksonville 140
Santa Clara 133
Beijing 119
Dallas 112
Seattle 104
Dearborn 100
Hefei 93
Cambridge 86
Rome 82
Chicago 78
The Dalles 73
Columbus 72
Princeton 70
Jakarta 61
Shanghai 61
Vienna 60
Boardman 59
Dong Ket 59
São Paulo 55
Nanjing 52
Seoul 52
Buffalo 48
Lauterbourg 40
Da Nang 39
Tokyo 39
Haiphong 37
Helsinki 37
Moscow 37
Montreal 35
Orem 35
Quận Bình Thạnh 33
Denver 31
Lawrence 31
Altamura 30
Monza 29
Phoenix 29
Ha Long 27
Munich 27
Guangzhou 26
Montréal 26
Boston 23
Florence 23
Johannesburg 23
San Diego 23
Atlanta 22
Lachine 22
Ninh Bình 22
Brussels 21
Hải Dương 21
Thái Nguyên 19
Warsaw 19
Amsterdam 18
Biên Hòa 18
London 18
Naples 18
Paris 18
Brooklyn 17
Bắc Giang 17
Can Tho 17
Fremont 17
Kent 17
Nanchang 17
Poplar 17
Rio de Janeiro 17
Salt Lake City 17
Vũng Tàu 17
Bologna 16
Genoa 16
Turin 16
Baghdad 15
Chennai 15
Hyderabad 15
Manchester 15
Nuremberg 15
Ottawa 15
Vinh 15
Bienno 14
Pune 14
Stockholm 14
Bergamo 13
Totale 11.560
Nome #
Early consequences of the phospholamban mutation PLN-R14del+/- in a transgenic mouse model 786
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 766
A new advanced cellular model of functional cholinergic-like neurons developed by reprogramming the human SH-SY5Y neuroblastoma cell line 703
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 701
First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand 688
Natural compounds in cancer prevention: effects of coffee extracts and their main polyphenolic component 5-CQA on oncogenic Ras proteins 646
Binding properties and biological characterization of new sugar-derived Ras ligands 639
Systems metabolomics: from metabolomic snapshots to design principles 629
Omics and Clinical Data Integration 587
Early consequences of the phospholamban mutation PLN-R14del+/− in a transgenic mouse model 524
K-ras activation induces differential sensitivity to sulfur amino acid limitation and deprivation and to oxidative and anti-oxidative stress in mouse fibroblasts 510
Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1 494
Profiling and Targeting of Energy and Redox Metabolism in Grade 2 Bladder Cancer Cells with Different Invasiveness Properties 487
Multi-level approach for the identification of structure-function relationships in neurofibromin type I protein 477
An Optimized Workflow for the Analysis of Metabolic Fluxes in Cancer Spheroids Using Seahorse Technology 454
A comparative study of Whi5 and retinoblastoma proteins: From sequence and structure analysis to intracellular networks 443
3D Modeling: Insights into the Metabolic Reprogramming of Cholangiocarcinoma Cells 439
Liraglutide preserves CD34+ stem cells from dysfunction Induced by high glucose exposure 428
Functional coupling of the mammalian EGF receptor to the Ras/cAMP pathway in the yeast Saccharomyces cerevisiae 401
Natural products attenuating biosynthesis, processing, and activity of ras oncoproteins: State of the art and future perspectives 399
RalGPS2 interacts with AKT and PDK1 promoting tunneling nanotubes formation in bladder cancer and kidney cells microenvironment 383
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 369
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits 361
Ras-dependent carbon metabolism and transformation in mouse fibroblasts 344
Extraction of methylxanthines by pressurized hot water extraction from cocoa shell by-product as natural source of functional ingredient 341
Mitochondrial dysfunction as a biomarker of frailty: The FRAMITO study protocol 338
Catalytic competence of the Ras-GEF domain of hSos1 requires intra-REM domain interactions mediated by phenylalanine 577 318
Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: A patent review (2007 present) 313
Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells 312
Characterization and properties of dominant-negative mutants of the ras specific guanine nucleotide exchange factor CDC25Mm 310
In Saccharomyces cerevisiae an unbalanced level of tyrosine phosphorylation down-regulates the Ras/PKA pathway 304
Tumor heterogeneity: preclinical models, emerging technologies, and future applications 301
Acquired glucose sensitivity of k-ras transformed fibroblasts 293
Glucagon-like peptide 1 receptor is a T cell negative costimulatory molecule 287
Comparative analysis of the molecular mechanisms controlling the initiation of chromosomal DNA replication in yeast and in mammalian cells 285
The isolated catalytic hairpin of the Ras-specific guanine nucleotide exchange factor Cdc25Mm retains nucleotide dissociation activity but has impaired nucleotide exchange activity 284
Progranulin Oncogenic Network in Solid Tumors 282
Regulation of hSos1 activity is a system-level property generated by its multi-domain structure 257
Archaean serine proteases 248
Carboxypeptidase Ss1 243
Identification and in silico analysis of a new group of double-histone fold-containing proteins 237
A system-level analysis of regulation of hSos1, the major activator of the Ras oncoprotein 236
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features 190
Large Extent of Convergent Evolution Towards the Double Histone Fold Revealed by Targeted Sequence and Structure Search Approach 155
FGFR3 oncogenic activation drives oxidative metabolic reprogramming in bladder cancer: a systems metabolomics approach 80
Exploiting hiPSCs-derived cardiomyocytes to recreate a human in vitro model recapitulating the heart failure phenotype 46
Recapitulating heart failure phenotype in vitro exploiting hiPSCs-derived cardiomyocytes 31
Recapitulating heart failure phenotype in vitro exploiting hiPSCs-derived cardiomyocytes 23
Totale 18.372
Categoria #
all - tutte 50.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.096 0 0 132 156 79 120 71 69 100 113 92 164
2022/20231.565 193 407 148 202 124 179 45 77 73 37 55 25
2023/20241.129 40 41 79 89 101 197 170 104 80 38 49 141
2024/20252.604 144 158 242 150 187 141 191 156 242 398 218 377
2025/20266.562 1.305 578 390 664 618 310 783 270 447 493 314 390
2026/2027874 281 276 317 0 0 0 0 0 0 0 0 0
Totale 18.372